Latest Articles

Publication Date
All News Scientific
MRI Phenotypes May Aid EC Risk Stratification - Physician's Weekly

MRI Phenotypes May Aid EC Risk Stratification Physician's Weekly

Published: Jan. 10, 2025, 11:34 p.m.
Read Full Article
University of Adelaide Awarded Funding for Innovative Health Initiatives Through NHMRC - India Education Diary

University of Adelaide Awarded Funding for Innovative Health Initiatives Through NHMRC India Education Diary

Published: Jan. 6, 2025, 10:17 a.m.
Read Full Article
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today

Published: Dec. 18, 2024, 8:16 p.m.
Read Full Article
Anogenital distance on MRI does not correlate to surgical diagnosis of endometriosis in patients without prior abdominal surgery - Nature.com

Anogenital distance on MRI does not correlate to surgical diagnosis of endometriosis in patients without prior abdominal surgery Nature.com

Published: Dec. 17, 2024, 11:30 a.m.
Read Full Article
Healthy Ideas Awarded Funding Through NHMRC Program - Mirage News

Healthy Ideas Awarded Funding Through NHMRC Program Mirage News

Published: Dec. 17, 2024, 5:38 a.m.
Read Full Article
Welsh Government launches women’s health plan - Nation.Cymru

Welsh Government launches women’s health plan Nation.Cymru

Published: Dec. 9, 2024, 12:23 p.m.
Read Full Article
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - BioSpace

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer BioSpace

Published: Dec. 6, 2024, 8:22 a.m.
Read Full Article
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - The Malaysian Reserve

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer The Malaysian Reserve

Published: Dec. 5, 2024, 3:36 p.m.
Read Full Article
Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - Canada NewsWire

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer Canada NewsWire

Published: Dec. 5, 2024, 2:43 p.m.
Read Full Article
NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer - OncLive

NMPA Grants Conditional Approval to Fruquintinib Plus Sintilimab for pMMR Endometrial Cancer OncLive

Published: Dec. 3, 2024, 5:11 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!